Satellos Bioscience Inc Common Stock
Yahoo Finance • last month
Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247
All four participants showed a decline in fat fraction as measured by MRI, with a mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to 46.0% at month 6, suggesting improved muscle composition All four participants showed an increas... Full story
Yahoo Finance • 2 months ago
Satellos Bioscience Announces Results of Annual Meeting of Shareholders
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases... Full story
Yahoo Finance • 4 months ago
Here Are Monday’s Top Wall Street Analyst Research Calls: Avis Budget, Carvana, Dow, Kratos Defense, Netflix, Northern Trust, PayPay,Twilio, Tyson Foods and More
Quick Read Traders and investors return from the long holiday weekend with an eye towards the beginning of the first-quarter earnings season, which starts in earnest next week on April 14th, when the large-cap financials report. Wall Stre... Full story
Yahoo Finance • 5 months ago
Satellos Bioscience GAAP EPS of -$1.70
* Satellos Bioscience press release [https://seekingalpha.com/pr/20453713-satellos-reports-2025-financial-results-and-highlights-recent-company-progress] (MSLE [https://seekingalpha.com/symbol/MSLE]): FY GAAP EPS of -$1.70. * Satellos... Full story